These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 9039073
1. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Grimm RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Hypertension; 1997 Jan; 29(1 Pt 1):8-14. PubMed ID: 9039073 [Abstract] [Full Text] [Related]
2. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. Grimm RH, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J. JAMA; 1997 Jan; 275(20):1549-56. PubMed ID: 8622245 [Abstract] [Full Text] [Related]
3. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R. JAMA; 1993 Aug 11; 270(6):713-24. PubMed ID: 8336373 [Abstract] [Full Text] [Related]
5. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Grimm RH, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Arch Intern Med; 1997 Mar 24; 157(6):638-48. PubMed ID: 9080918 [Abstract] [Full Text] [Related]
6. The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med; 1991 Jul 24; 151(7):1413-23. PubMed ID: 2064494 [Abstract] [Full Text] [Related]
7. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH, Neaton JD, Stamler J. Circulation; 1995 Feb 01; 91(3):698-706. PubMed ID: 7828296 [Abstract] [Full Text] [Related]
8. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA; 2000 Apr 19; 283(15):1967-75. PubMed ID: 10789664 [Abstract] [Full Text] [Related]
9. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD, ALLHAT Collaborative Research Group. Ann Intern Med; 2002 Sep 03; 137(5 Part 1):313-20. PubMed ID: 12204014 [Abstract] [Full Text] [Related]
10. Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS). Mascioli SR, Grimm RH, Neaton JD, Stamler J, Prineas RJ, Cutler JA, Elmer PJ, McDonald R, Schnaper H, Schoenberger J. Am J Cardiol; 1990 Sep 25; 66(9):32C-35C. PubMed ID: 2220647 [Abstract] [Full Text] [Related]
11. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Wassertheil-Smoller S, Blaufox MD, Oberman A, Davis BR, Swencionis C, Knerr MO, Hawkins CM, Langford HG. Ann Intern Med; 1991 Apr 15; 114(8):613-20. PubMed ID: 2003706 [Abstract] [Full Text] [Related]
12. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S, ALLHAT Collaborative Research Group. Circulation; 2008 Nov 25; 118(22):2259-67. PubMed ID: 19001024 [Abstract] [Full Text] [Related]
13. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Wright JT, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR. Arch Intern Med; 2008 Jan 28; 168(2):207-17. PubMed ID: 18227370 [Abstract] [Full Text] [Related]
14. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474 [Abstract] [Full Text] [Related]
15. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647 [Abstract] [Full Text] [Related]
16. [ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug]. Slany J. Wien Klin Wochenschr; 2003 Mar 31; 115(5-6):149-51. PubMed ID: 12741071 [No Abstract] [Full Text] [Related]
17. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial. Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kwan J, Yoon MH, Lee KJ, Lim DS. Clin Ther; 2006 Apr 31; 28(4):537-51. PubMed ID: 16750465 [Abstract] [Full Text] [Related]
18. Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats. Lin LL, Wang D, Wang W, Cheng YQ, Su DF, Liu AJ. PLoS One; 2015 Apr 31; 10(1):e0116155. PubMed ID: 25615941 [Abstract] [Full Text] [Related]
19. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM, ALLHAT Collaborative Research Group. J Clin Hypertens (Greenwich); 2002 Apr 31; 4(6):393-404. PubMed ID: 12461301 [Abstract] [Full Text] [Related]
20. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial. Jo SH, Park SJ, Kim EJ, Kim SJ, Cho HJ, Song JM, Shin J, Park JJ, Shin JH, Han KR, Choi DJ. Trials; 2018 Jun 20; 19(1):324. PubMed ID: 29925421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]